Article: FACTOR ASSAYS FOR MONITORING rFVIIIFc AND rFIXFc: MUCH ADO ABOUT NOTHING?

Related products

• 

  Article: Highlights in gynaecological cancers

  €2.42 Add to cart
• 

  Article: Calendar of events

  €2.42 Add to cart
• 

  Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

  €2.42 Add to cart
• 

  Article: Highlights in urologic cancer

  €2.42 Add to cart